Last reviewed · How we verify
Provigil
At a glance
| Generic name | Provigil |
|---|---|
| Sponsor | Sheba Medical Center |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Cognitive Strategies in Early Psychosis 2 (PHASE3)
- Cognitive Strategies in Early Psychosis 1 (PHASE3)
- RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia) (PHASE2)
- RECOVER-SLEEP: Platform Protocol (PHASE2)
- Modafinil and Cognitive Function in POTS (EARLY_PHASE1)
- Modafinil to Improve Fatiguability (PHASE1, PHASE2)
- Modafinil For Fatigue in IBD: A Feasibility Randomised Controlled Trial (PHASE2)
- Investigation of Locus Coeruleus Function in Sustained Attention (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Provigil CI brief — competitive landscape report
- Provigil updates RSS · CI watch RSS
- Sheba Medical Center portfolio CI